Top 100 Drugs Flashcards

(89 cards)

1
Q

Side Effects - Sodium Valporate

A

Valproate
Appetite increase, so weight gain
Liver failure (monitor LFTs during 1st 6 months)
Pancreatitis
Reversible hair loss (grows back curly, apparently)
Oedema
Ataxia
Teratogenicity, Tremor, Thrombocytopaenia
Encephalopathy (due to hyperammonaemia) / Enzyme inducer
Has the greatest risk of fetal abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Indications - Sodium Valporate

A

Seizure prophylaxis in epilepsy

Manic episodes in bipolar disorder - used as prophylaxis against recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraindications - Sodium Valporate

A

Women of child-bearing age - especially time of conception and pregnancy
Hepatic Impairment
Renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aminosalicylates - Indications

A

Mesalazine - 1st line mild/moderate UC

Sulfasalazine - Used with a DMARD in rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Side Effects - Aminosalicylates

A

Nausea
Dyspepsia
Headache
Blood Abnormalities - leucopenia and thrombocytopenia (rare)
Oligospermia
Can cause severe hypersensitivity reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications - Aminosalicylates

A

Not given to those with aspirin hypersensitivity

Mesalazine - pH sensitive coating - affected by PPIs and Lactulose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PPI - Indications

A

Peptic ulcer disease
NSAID-associated ulcers
Symptomatic relief of dyspepsia and GORD
H. pylori infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PPI - Mechanism

A

Irreversibly inhibit H+/K+ ATPase in gastric parietal cells

Suppress gastric acid production almost completely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PPI - Adverse effects

A

GI disturbances
Headache
Prolonged treatment - hypomagnesaemia - severe can lead to tetany

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PPI - Warnings

A

May disguise symptoms of gastro-oesophageal cancer

Cautioned in those with osteoporosis - increased risk of fracture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PPI - Interactions

A

Reduce antiplatelet affect of clopidogrel by decreasing its activation of cytochrome P450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metronidazole - Indications

A

Antibiotic-associated colitis - gram-positive anaerobe Clostridium difficile
Oral Infections / Aspiration pneumonia
Surgical and gynae infections by gram-negative anaerobes
Protozoal infections - trichomonal vaginal infection, amoebic dysentery and giardiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metronidazole - Mechanism

A

Anaerobic Bacteria - DNA degradation and cell death (bactericidal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metronidazole - Adverse Effects

A

GI upset (nausea and vomiting)
Delayed Hypersensitivity reactions -
Can cause peripheral and optic neuropathy, seizures and encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Metronidazole - Warnings

A

Metabolised by P450 enzymes - reduced in people with severe liver disease
Inhibits acetaldehyde dehydrogenase - responsible for clearing alcohol metabolite
Alcohol should not be drunk while taking metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metronidazole - Interactions

A

Some inhibitory effect on CYP enzymes

Reduction in warfarin metabolism and phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cephalosporins - examples?

A

Ceftriaxone, Cefalexin, Meropenem, Ertapenem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ceftriaxone - Mechanism

A

3rd generation cephalosporin
Broad-spectrum - long half-life
Penetrates the meninges, eyes and inner ear
Used in the treatment of bacterial infections caused by susceptible usually gram-positive
Ceftriaxone works by inhibiting the mucopeptide synthesis in the bacterial cell wall
Prevents them from maintaining an osmotic gradient leading to bacterial cell swelling and death
Has in vitro activity against gram-positive aerobic, gram-negative aerobic, and anaerobic bacteria
Bactericidal activity of ceftriaxone results from the inhibition of cell wall synthesis and is mediated through ceftriaxone binding to penicillin-binding proteins (PBPs)
Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended-spectrum beta-lactamases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ceftriaxone - Cautions

A

Ceftriaxone should not be mixed with or giving in the same IV line as diluents/products containing calcium as they may cause ceftriaxone to precipitate.
In those at increased C. difficile infection
Epilepsy
Cautioned in those with renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ceftriaxone - Adverse Effects

A

Ceftriaxone use may also cause biliary sludge or gallbladder pseudolithiasis.
GI upset
Antibiotic associated colitis -> can lead to bowel perforation and death
Clostridium difficile infections
Hypersensitivity -> Cross-reactivity can occur in penicillin allergic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ceftriaxone - Interactions

A

Enhance anticoagulant effects of warfarin by killing normal gut flora that synthesise vitamin K
Increase nephrotoxicity of aminoglycosides
Reduce conc. of valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Methotrexate - Mechanism

A

DMARD for rheumatoid arthritis
Chemotherapy regimen for cancers: leukaemia, lymphoma and some solid tumours
Treatment of severe psoriasis
Mechanism of action
Folic analogue inhibits dihydrofolate reductase (which converts dietary folate to tetrahydrofolate -needed for DNA synthesis) and thymidylate synthase - reduce production of thymine needed for DNA synthesis –> prevents cellular replication
Anti-inflammatory and immunosuppressive - inhibition of inflammatory mediators IL-6, IL-8 and TNF-alpha
Reduction in methionine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Methotrexate - Adverse Effects

A

Mucosal damage
Bone marrow suppression (can lead to neutropenia and increased infection risk)
Hypersensitivity reactions - cutaneous reactions, hepatitis, pneumonitis
Long term can lead to hepatic cirrhosis or pulmonary fibrosis
Renal failure and hepatic toxicity
Risk of accidental overdose - treated with folinic acid which rescues normal cells from methotrexate effects along with hydration and urinary alkalinisation - enhance excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Methotrexate - Contraindicated

A

Teratogenic - avoided in pregnancy (both men and women)
Severe renal impairment
Abnormal liver function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Methotrexate - Interactions
Toxicity likely with drugs that can inhibit its renal excretion - NSAIDs, penicillins Co-prescription with other folate antagonists (Trimethoprim and phenytoin) can lead to haematological abnormalities
26
Dexamethasone (Glucocorticoids - systemic corticosteroids) - Mechanism
Used to treat allergic or inflammatory disorders Suppression of autoimmune disease Cancer treatment as part of chemotherapy or to reduce tumour associated swelling Hormone replacement in adrenal insufficiency or hypoparathyroidism Mechanism of Action Bind to the glucocorticoid receptor - inhibiting pro-inflammatory signals (cytokines and TNF-alpha) and promoting anti-inflammatory signals Decreased vasodilation and permeability of capillaries Suppression of circulating monocytes and eosinophils Gluconeogenesis from increased circulating fatty acids and amino released by fat and muscle catabolism Mineralocorticoid effect - Na+ retention and K+ excretion
27
Dexamethasone (Glucocorticoids - systemic corticosteroids) - Adverse Effects
Immunosuppression - increases the risk and severity of infection - alters host response Increased catabolism - proximal muscle weakness, skin thinning with easy bruising and gastritis Mood and behavioural changes - insomnia, confusion, psychosis Hypertension, hypokalaemia and oedema Suppresses ACTH production - in prolonged treatment leads to adrenal atrophy If steroids are withdrawn too quickly - Addisonian crisis Needs to be withdrawn slowly by can cause symptoms of chronic glucocorticoid deficiency Cannot produce cortisol secretion in response to stress - needs to be provided artificially in acute illness (double dose)
28
Dexamethasone (Glucocorticoids - systemic corticosteroids) - Contraindicated
§ Those with infection | § Children
29
Dexamethasone (Glucocorticoids - systemic corticosteroids) - Interactions
Peptic ulcers and GI bleeding - especially if used with NSAIDs Hypokalaemia enhancement with those on Beta-2 agonists, theophylline (PDE inhibitor), loop and thiazide diuretics Efficacy reduced by cytochrome P450 inducers (phenytoin, carbamazepine, rifampcin)
30
Calcium Gluconate - Indications
Used in beta blocker and Calcium Channel Toxicity Severe acute hypocalcaemia or hypocalcaemic tetany Acute severe hyperkalaemia (plasma-potassium concentration above 6.5 mmol/litre or in the presence of ECG changes) Calcium deficiency, Mild asymptomatic hypocalcaemia Hyperkalaemia is common among hospital inpatients First line emergency treatment for severe hyperkalaemia associated with ECG abnormalities
31
Calcium Gluconate - Dosage
10mL of calcium gluconate 10% IV over 10-15 minutes
32
Calcium Gluconate - Mechanism of Action
○ In hyperkalaemia - calcium raises the myocardial threshold potential, reducing excitability and the risk of arrhythmias - no effect on serum potassium
33
Calcium Gluconate -Contraindicated
Conditions associated with hypercalcaemia (e.g. some forms of malignant disease)
34
Allopurinol - Indications
Prevent recurrent attacks of gout Thiazide or loop diuretics - increases serum uric acid Aspirin inhibits renal excretion of uric acid Drug-induced gout C Prevent uric acid and calcium oxalate renal stones Prevent hyperuricaemia and tumour lysis syndrome
35
Allopurinol - Mechanism of Action
Xanthine oxidase inhibitor | Xanthine oxidase metabolises xanthine from purines to uric acid
36
Allopurinol - Adverse Effects
Initially can worsen gout attacks - can be prevented with co-prescription with an NSAIDs or colchicine during initiation of treatment Allopurinol hypersensitivity syndrome - rare Can cause Stevens-Johnson Syndrome or toxic epidermal necrolysis
37
Allopurinol - Cautions
Shouldn't be started during acute attacks of gout but can be continued if patient is already on it Renal and hepatic impairment
38
Allopurinol - Interactions
``` Active metabolite (mercaptopurine) - of the pro-drug azathioprine metabolised by xanthine oxidase Co-prescription with ACE inhibitors or thiazides can increase risk of hypersensitivity and with amoxicillin can increase the risk of skin rash ```
39
Rasburicase - Mechanism of Action
Recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukaemias and non-Hodgkin's lymphoma. Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin). The injection of rasburicase reduces levels of uric acid and mitigates the toxic effects of chemotherapy induced tumour lysis
40
Rasburicase - Contraindicated
G6PD deficiency
41
Rasburicase - Cautioned
Atopic Allergies
42
Rasburicase - Adverse Effects
Diarrhoea, fever, headache, nauseas, skin reactions, vomiting Haemolytic anaemia, hypersensitivity, hypotension
43
Piptazobactam - Interactions
Antipseudomonal penicillins -> reserved for severe infections (antibiotic resistance or in immunocompromised (neutropenic) individuals) Tazobactam is the beta - lactamase inhibitor (confers activity against beta-lactam producing Staphylococcus aureus and gram-negative anaerobes) Clinical infections treated: LRTIs UTIs Intraabdominal sepsis Skin and soft tissue infections
44
Piptazobactam - Mechanism of Action
Responsible for cross-linking peptidoglycan in bacterial cell walls - weakens walls preventing them from maintaining their osmotic gradient
45
Piptazobactam - Adverse Effects
GI upset - nausea and diarrhoea Clostridium difficile Rare- antibiotic - associated colitis
46
Piptazobactam - Warnings
Cautioned in those with a C. difficile infection Contraindicated in penicillin allergy People with penicillin allergy would react to cephalosporins and other B-lactam antibiotics
47
Piptazobactam - Interactions
Pencillins reduce renal excretion of methotrexate - can increase toxicity Enhance anticoagulant effects of warfarin by killing normal GI flora that synthesise vitamin K Each dose of piperacillin - tazobactam contains 11mmol Na+ and is infused in 50-150mL fluid - needs to be considered when prescribing fluids in heart failure patients
48
Gentamicin - Aminoglycoside - Indications
Used to treat severe infections - caused by gram-negative aerobe (including pseudomonas aerunginosa): □ Severe sepsis □ Pyelonephritis and complicated UTIs □ Biliary and other intraabdominal sepsis □ Endocarditis Topical - bacterial skin and ear infections
49
Gentamicin - Aminoglycoside - Warnings
Has a very narrow therapeutic index - little safety margin between clinically effective dose and toxic dose - aminoglycosides distribute through body water not fat - needs to be the basis of the dosage given Warnings: □ Renally excreted □ Not be given in patients with myasthenia gravis □ Neonates, elderly patients and those with renal impairment
50
Gentamicin - Aminoglycosides - Mechanism of Action
Mechanism of Action Against gram-negative aerobic bacteria - some activity against staphylococci and mycobacteria - other agents preferred in practice Inactive against streptococci and anaerobes - need to be combined with penicillin and/or metronidazole - when organism is unknown Binds irreversibly to bacterial ribosomes (30S subunit) - inhibit protein synthesis -inhibit protein synthesis Are bactericidal As pencillins weaken bacterial cell walls - may enhance aminoglycoside - increase bacterial uptake via oxygen - dependent transport system which streptococci and anaerobic bacteria don't have
51
Gentamicin - Aminoglycosides - Adverse Effects
Nephrotoxicity (reduced urine output and rising serum creatinine and urea) can be reversible and otoxicity (hearing loss, tinnitus or vertigo) is irreversible - accumulate in tubular epithelial cells and cochlear and vestibular hair cells - trigger apoptosis and cell death
52
Gentamicin - Aminoglycosides - Interactions
Ototoxicity more likely if co-prescribed with loop diuretics (e.g. furosemide) or vancomycin Nephrotoxicity more likely is co-prescribed with ciclosporin, platinum chemotherapy, cephalosporins or vancomycin
53
Anti-muscarinics, bronchodilators - Indications
COPD - short acting muscarinics - relieve breathlessness (brought on by exercise or during exacerbations) LAMAS - used to prevent breathlessness and exacerbations Asthma - short-acting anti-muscarinic used to help relieve breathlessness during acute exacerbations (added to a short -acting beta-2- agonist e.g. salbutamol). LAMAs (tiotroprium) - added to high dose inhaled corticosteroids and long-acting beta-2 agonists (LABA) as maintenance treatment - patients 1 or more severe asthma exacerbations in the past year
54
Anti-muscarinics, bronchodilators - Examples
Ipratropium, tiotropium, Glycopyrronium, Aclidinium
55
Anti-muscarinics, bronchodilators - Mechanism of action
Competitive inhibitor of acetylcholine Reduce smooth muscle tone, including the respiratory tract and bladder and reduce secretions from the glands in the respiratory and GI tracts Relaxation of the pupillary constrictor and ciliary muscles - pupil dilation + prevent accommodation No advantaged in prescribing more than 4 times daily
56
Anti-muscarinics, bronchodilators - Adverse Effects
Inhaled - rapidly metabolised - less effects Nasopharyngitis, sinusitis and cough, GI disturbance (including dry mouth and constipation and urinary retention, blurred vision and headaches)
57
Anti-muscarinics, bronchodilators - Warnings
Cautioned in patients with - angle - closure glaucoma (can cause a rise in intra-ocular pressure) Cautioned in patients with urinary retention and arrhythmias
58
Beta 2 Agonists - Indications
Asthma - SABAs relieve breathlessness LABAs used in chronic asthma when inhaled corticosteroids are insufficient - need to be given with inhaled corticosteroids COPD - SABAs relieve breathlessness LABAs 2nd line therapy of COPD - improve symptoms and reduce exacerbations Hyperkalaemia - neubulised used to lower serum potassium (given along with insulin and glucose and calcium gluconate to stabilise the myocardium)
59
Beta 2 Agonists - Mechanism of Action
Smooth muscles relaxation - G - protein coupled receptors Stimulate Na+/K- ATPase pumps on cell surface - K+ shifts from extracellular to intracellular compartments Useful adjunct in hyperkalaemia - not used in isolation
60
Beta 2 agonist - Adverse effects
Flight or fight - tachycardia, palpitations, anxiety and tremor Glycogenolysis - increase serum glucose High dose - serum lactate goes up Long term - muscle cramps
61
Beta 2 agonist - Warnings
LABA - only used with an inhaled corticosteroid | Cautioned in those with CVS risks - can induce tachycardias or arrhythmias
62
Beta 2 agonists - Interactions
Beta-blockers High nebulised doses of beta - 2 agonists with theophylline and corticosteroids - lead to hypokalaemia - serum K+ needs to be monitored
63
Beta 2 agonists - Nebuliser Therapy
Indicate whether the nebuliser should be driven by oxygen or air Oxygen should be used in asthma whereas medical air should be used in COPD - due to risk of CO2 retention
64
Inhaled Corticosteroids - Indications
Asthma - treat airway inflammation (usually combined with SABA) COPD - Control symptoms and prevent exacerbations - people with severe airway obstruction on spirometry and recurrent exacerbations (usually combined with a LABA)
65
Inhaled Corticosteroids - Mechanisms of Action
Reduction in mucosal inflammation, widens the airways and reduced mucus secretion
66
Inhaled Corticosteroids - Adverse Effects
Immunosuppression - oral candidiasis - need to rinse mouth after use Hoarse voice in COPD High dose - release into systemic - adrenal suppression, growth retardation and osteoporosis
67
Inhaled Corticosteroids - Warnings
Cautioned at a high - dose in patients with a history of pneumonia and in children at risk of growth suppression
68
Leukotriene receptor antagonist - Montelukast - Indications
Adults: Add on if not controlled well by inhaled corticosteroids and LABAs Children 5-12: alternative to LABAs where inhaled corticosteroids are insufficient Children under 5 years: 1st line preventative therapy in young children with asthma who cannot take steroids
69
Leukotriene receptor antagonist - Montelukast - Mechanism of Action
Blocking the CysLT1 receptor and damping down the inflammatory cascade
70
Leukotriene receptor antagonist - Montelukast - Adverse Effects
Usually well-tolerated Mild Headache and abdominal pain Increased rate of URTIs Rare- hyperactivity
71
Leukotriene receptor antagonist - Montelukast - Warnings
Not prescribed unless incompletely controlled with inhaled corticosteroids and LABAs
72
Adrenaline - Indications
Cardiac Arrest - Advanced Life Support - treatment algorithm for shockable and non-shockable rhythms Anaphylaxis Injected directly into tissues to induce local vasoconstriction - used in endoscopy to control mucosal bleeding - sometimes mixed with local anaesthetic to control mucosal bleeding - sometimes mixed with local anaesthetic drugs (e.g. lidocaine) to prolong local anaesthetic
73
Adrenaline - Adverse Effects
Restoration os cardiac output - followed by adrenaline -induced hypertension When given to conscious patients in anaphylaxis or in an attempt to produce local vasoconstriction - often causes anxiety, tremor, headache and palpitations Patients with existing heart problems - angina, MI and arrhythmias
74
Adrenaline - Warnings
None in cardiac arrest or anaphylaxis For local vasoconstriction - should be given with caution in patients with heart disease Adrenaline - anaesthetic preparations should not be given in areas supplied by an end-artery - fingers and toes - can cause tissue necrosis
75
Adrenaline - Interactions
In patients on beta-blockers - may induce widespread vasoconstriction
76
Adrenaline - Warnings
None in cardiac arrest or anaphylaxis For local vasoconstriction - should be given with caution in patients with heart disease Adrenaline - anaesthetic preparations should not be given in areas supplied by an end-artery - fingers and toes - can cause tissue necrosis
77
Anti-histamine - Indications
Allergy Relief pruritis and hives (urticaria) due to insect bites, infections and drug allergies Adjunct treatment in anaphylaxis after administration of adrenaline Other class used in nausea and vomiting
78
Anti- histamine - Adverse Effects
1st generation antihistamine (e.g. chlorophenamine) cause sedation - histamine has a role in wakefulness 2nd generation antihistamine (e.g. loratadine, cetirizine and fexofenadine) do not cross the blood - brain barrier - have fewer adverse effects
79
Anti-histamine - Warnings
Mainly safe | Cautioned in patients with severe liver disease - may precipitate hepatic encephalopathy
80
Adenosine - Indications
As a first line diagnostic and therapeutic agent in supraventricular tachycardia (SVT), usually evident on the ECG as a regular, narrow - complex tachycardia
81
Adenosine - Mechanisms of Action
Adenosine is an agonist of adenosine receptors on cell surfaces. In the heart, activation of these G-protein coupled receptors induces severe effects, including reducing the frequency of spontaneous depolarisation (automacity) and increasing resistance to depolarisation (refractoriness) In turn, this transiently slows the sinus rate and conduction velocity and increases the AV node refractoriness. Many forms of SVT arise from a self-perpetuating electrical (re-entry) circuit that takes in the AV node Increasing refractoriness in the AV node breaks the re-entry circuit, which allows normal depolarisations from the sinoatrial (SA) node to resume control of heart rate (cardioversion). Where the circuit does not involve the AV node (e.g. in atrial flutter), adenosine will not induce cardioversion. However by blocking conduction to the ventricles, it allows closer inspection of the atrial rhythm on the ECG This may reveal the diagnosis The duration of effect of adenosine is very short because it is rapidly taken up by cells (e.g. red cells) Its half-life in plasma is less than 10 seconds
82
Adenosine - Adverse Effects
Can induce bradycardia and even asystole Deeply unpleasant sensation for the patient Sinking feeling in the chest - accompanied by breathlessness and a 'sense of impending doom' Usually short-lived
83
Adenosine - Warnings
Should not be administered to patients that cannot tolerate its transient bradycardic effects e.g. those with hypotension, coronary ischaemia, decompensated heart failure Adenosine may induce bronchospasm in susceptible individuals so should be avoided in patients with asthma or COPD Patients who have had a heart transplant are very sensitive to the effects of adenosine
84
Adenosine - Interactions
Dipyridamole, an antiplatelet agent, blocks cellular uptake of adenosine. This prolongs and potentiates its effect, so the dose of adenosine should be halved. Theophylline and aminophylline (systemic bronchodilators) are competitive antagonists of adenosine receptors and reduce its effect. Patients who have taken these drugs respond poorly and may require higher doses
85
Amiodarone - Indications
Used to treat a wide range of tachyarrhthymias, including atrial fibrillation (AF), atrial flutter, supraventricular tachycardia (SVT), ventricular tachycardia (VT). Used when other therapeutic options (drugs or electrical cardioversion) are ineffective or inappropriate
86
Amiodarone - Mechanism of Action
Has many effects on myocardial cells, including blockade of sodium, calcium and potassium channels and antagonism of alpha and beta - adrenergic receptors. There effects reduce spontaneous depolarisation (automaticity), slow conduction velocity and increase resistance to depolarisation (refractoriness), including in the AV node. By interfering with AV node conduction, amiodarone reduces the ventricular rate in AF and atrial flutter. Through its other effects it may also increase the chance of conversion to and maintenance of sinus rhythm. In SVT involving a self-perpetuating ('re-entry') circuit that includes the AV node, amiodarone may break the circuit and restore sinus rhythm. Amiodarone's effects in suppressing spontaneous depolarisations make it an option for both treatment and prevention of VT and for improving the chance of successful defibrillation in refractory VF.
87
Amiodarone - Adverse Effects
In acute use, compared with other anti-arrhythmic drugs, amiodarone causes relatively little myocardial depression. It can cause hypotension during IV infusion, although this is probably an effect of the solvent with which it is formulated, rather than the drug itself. When taken chronically, amiodarone has many side effects, several of which are serious. These include effects on the lungs (pneumonitis), heart (bradycardia, AV block), liver (hepatitis) and skin (photosensitivity and grey discolouration). Due to its iodine content (amIODarone) and structural similarities to thyroid hormone, it may cause thyroid abnormalities, including hypo- and hyperthyroidism. Amiodarone has an extremely long half-life. After discontinuation, it may take months to be completely eliminated
88
Amiodarone - Warnings
Amiodarone is a potentially dangerous drug that should be used only when the risk-benefit balance justifies this. It should generally be avoided in patients with increased severe hypotension, increased heart block, and increased active thyroid disease.
89
Amiodarone - Interactions
Amiodarone interacts with many drugs. Increases the plasma concentrations of digoxin, diltiazem and verapamil. This may increase the risk of bradycardia, AV block and heart failure. The doses of these drugs should be halved if amiodarone is started